Top Tweets for #Altto
New #ALTTO analysis (>4,100 pts) confirms that #PMRT remains important in #HER2-positive early #BreastCancer.
✅ Clear benefit in patients with ≥4 positive nodes (pN2): improved LRR, TTDR, DFS & OS.
❓Benefit in pN1 is uncertain.
❌ No benefit in pN0.
https://t.co/PP2f9SvB7x
☀️Good morning #OncTwitter #bcsm! Grab some ☕️coffee and check out this discussion between @OncBrothers and @laura_huppert on 🔑 abstracts at #SABCS25 in HR+ early breast cancer!
⭐️#ALTTO
⭐️#lidERA
⭐️#NATALEE, and more!
#MedTwitter #MedX #BreastCancer
https://t.co/DEgbCFWJJA
3 Early stage HR+ Breast Ca studies that we touched on with @laura_huppert for #SABCS25:
✅ #ALTTO (update)
✅ #lidERA
✅ #NATALEE (update)
#OncTwitter #MedTwitter @OncUpdates @OncoAlert @SABCSSanAntonio @AACR
Early Stage HR+ #BreastCancer conf highlights from #SABCS25 w/ @laura_huppert:
✅ #ALTTO update
✅ #lidERA
✅ #NATALEE update
Full Discussion:
⭐️ https://t.co/BxOylSrchZ
⭐️ Also on “Oncology Brothers” podcast
#OncTwitter #bcsm @OncoAlert @OncUpdates
Early Stage HR+ #BreastCancer conf highlights from #SABCS25 w/ @laura_huppert:
✅ #ALTTO update
✅ #lidERA
✅ #NATALEE update
Full Discussion:
⭐️ https://t.co/BxOylSrchZ
⭐️ Also on “Oncology Brothers” podcast
#OncTwitter #bcsm @OncoAlert @OncUpdates
How does HER2+ ILC fare long-term? #ALTTO data
⬆️ CNS relapse risk in ILC vs NST (13.6% vs 5.0%; HR 3.14)
– DFS & OS similar despite clinicopathologic differences
– Importance of central histology review
Poster BD135 | #ASCO25 – come by!
@OncoAlert
Long-term outcomes in HER2+ early breast cancer with special histologies explored in #ALTTO—results support the efficacy of trastuzumab-based therapy across subtypes
Congrats @RGerosaMD!
#ESMOBreast25 @DMBranco @E_de_Azambuja @BIGxResearch
@myESMO
What were the long-term outcomes for patients with HER2+ early breast cancer and rare special histologies in the ALTTO trial?
Pass by @RGerosaMD and his poster at #ESMOBreast25
@GuiNaderMarta @DMBranco @E_de_Azambuja @BIGxResearch
Nice results from this #ALTTO exploratory analysis: no detrimental effect of erythropoietin stimulating agents in adjuvant treatment of #patients with HER-2 POSTIVE #breastcancer @DMBranco @VeroniqueDebien @BIGagainstBC @OncoAlert @Frontier_SF @JulesBordet
📢 #Erythropoiesis stimulating agents were #safe & not detrimental on #survival of pts under adjuvant anti-HER2 for #HER2+ early #bcsm
📉 #ALTTO sub-analysis
🗞 The largest retrospective analysis of this topic in #HER2+ early #bcsm @ BCRT
👉 https://t.co/unsEViDls6
@OncoAlert
📢 #Erythropoiesis stimulating agents were #safe & not detrimental on #survival of pts under adjuvant anti-HER2 for #HER2+ early #bcsm
📉 #ALTTO sub-analysis
🗞 The largest retrospective analysis of this topic in #HER2+ early #bcsm @ BCRT
👉 https://t.co/unsEViDls6
@OncoAlert
📢 Long-term outcomes (7y mFUP) of a large cohort of pts (N=2,821) with small (<3cm), N0 HER2+ #breastcancer treated with anti-HER2 Tx in #ALTTO
❕7-year OS of 95.9%
Just out in @BrJCancer #bcsm
https://t.co/Zvpfj9aWaQ
Our Dear friend @CarmineDeA1 🇮🇹
Presenting some important data on impact of #statin and #bisphosphonates use in #HER2+ early #BreastCancer in the #ALTTO trial
Check it out‼️
A huge Hug to Carmine and our Italian Friends at #ASCO22 🌐
Poster session at #ASCO22 on #BreastCancer: important data presented by @CarmineDeA1 on impact of #statin and #bisphosphonates use in #HER2+ early disease in the #ALTTO trial
@OncoAlert @E_de_Azambuja @BIGagainstBC @mfrimawi @ConquerCancerFd @BCRFcure @NIH
Poster session at #ASCO22 on #BreastCancer: important data presented by @CarmineDeA1 on impact of #statin and #bisphosphonates use in #HER2+ early disease in the #ALTTO trial
@OncoAlert @E_de_Azambuja @BIGagainstBC @mfrimawi @ConquerCancerFd @BCRFcure @NIH
🔙 to @SABCSSanAntonio
🚨 EPO administration in pts receiving adj anti-HER2 tx for HER2+ #EBC was safe and had no detrimental impact on survival outcomes.
👇 Here is our poster and a video abstract of the main results.
#SABCS21 #bcsm #ALTTO @OncoAlert
Diogo Martins-Branco (@DMBranco) of @JulesBordet discusses ALTTO: impact of EPO administration concomitantly with adjuvant anti-HER2 treatment on patient outcomes
Watch: 👉https://t.co/rn1UuHPowt👈
@SABCSSanAntonio #SABCS21 #BCSM #BreastCancer @AACR
While waiting for #ASCO21 Plenary Session, don't miss to stop by the poster of super @ElisaAgostinett from @JulesBordet reporting on the (poor) prognostic performance of #PREDICT+ in #HER2+ early #BreastCancer (data from @BIGagainstBC #ALTTO)
@OncoAlert
https://t.co/5fmAF1uihw
Kuorolaisen torstai-ilta: blogitekstiä uusille nettisivuille, harkat Teamsissä ja omaa stemmaa pianolla. 🤩 Saila-altto ❤️
#sekakuoro #hybridikuoro #etätreenit #altto
#BodyMassIndex and #Weight Change in Pts With #HER2-Positive Early #BreastCancer: Exploratory Analysis of the #ALTTO BIG 2-06 #Trial by @matteolambe @E_de_Azambuja @SamuelMartel87 @noam_ponde
@Maurer_Oncology @ChristineDesme2 @serenadicosimo et al.
https://t.co/mddMRPxXtE
NOW ONLINE | New study by Amir Sonnenblick, Dominique Agbor‐tarh, Evandro de Azambuja @E_de_Azambuja, et al.
Read it here!
➡️https://t.co/6bXajXrKe4
#STAT3 #HER2 #BreastCancer #ALTTO
@TelAvivUni
@JulesBordet
Almost ready for the #SABCS20 Poster Spotlight session 3 with our @BIGagainstBC exploratory analysis of the #ALTTO trial assessing the prognostic value of #trastuzumab-free interval
@OncoAlert @E_de_Azambuja @Otto_DFCI @noam_ponde @Poggio_Fra @delmastro_lucia #UNIGEnonsiferma
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers